New review highlights often-missed symptoms of MG
Nonmotor symptoms including depression, memory problems, gastrointestinal issues and cardiovascular abnormalities can affect people with MG.
News
-
-
Vascular diseases a significant cause of mortality in patients with MG
Vascular and respiratory diseases contribute significantly to MG-associated deaths.
-
Single dose of efgartigimod helps MG patients before thymectomy
A single presurgery dose of efgartigimod can be a helpful temporary treatment for MG patients waiting for a thymectomy.
-
New research suggests long-term benefits of rituximab for new-onset MG
Rituximab offers a promising option for managing MG. However, further research is needed to fully assess its long-term benefit-risk profile.
-
Early thymectomy improves remission in ocular myasthenia gravis
Patients with ocular myasthenia gravis who undergo thymectomy before generalization are more likely to achieve lasting remission.
-
New data indicates inebilizumab improves quality of life in MG
A monoclonal antibody used to treat two rare autoimmune diseases improved quality-of-life in patients diagnosed with generalized MG.
-
Study identifies possible link between mitochondrial proteins and MG
Some proteins inside mitochondria may raise the risk of myasthenia gravis (MG), while others may help protect against it.
-
New research indicates MG is on the rise in the US
New data show increasing incidence and prevalence of myasthenia gravis in U.S. adults, with high exacerbation rates.
-
New study shows benefits of structured exercise for people with MG
Physical and respiratory rehabilitation therapy is associated with significant benefits for patients with myasthenia gravis (MG).
-
People with myasthenia gravis less likely to engage socially with others
To improve social participation, various life-limiting disease manifestations must first be adequately addressed.
